Are you overwhelmed by the continuous messages about medication safety and treatment efficacy that flood your inbox but aren't relevant to your practice?
Why not let the editors at M.J Powers & Co sift through the mountains of information for you? We will provide you with a single comprehensive monthly update that includes only the information you need in a manageable format (either in print or online). You will not only stay abreast of the latest developments, but save time while doing so. Plus you can earn continuing education credits too.
MJ Powers & Co publishes monthly newsletters about the efficacy and safety of drugs and therapeutics. The Alerts contain summaries, from a wide variety of journals, that can help you solve a problem, warn you about safety, or reassure you about efficacy. Not only will you receive the latest research findings, but also useful tools to help you judge research quality, evaluate study independence, and guide you with statistics.
The Alerts Newsletters are timely and thorough, and you can be assured of objectivity because MJ Powers & Co is independent. There is no sponsorship associated with any of our newsletters, and we accept no advertising.
In addition, as a subscriber you will be eligible to enroll in our CME program, which your colleagues consistently rate as "excellent" and "practice changing".
- Ketamine for Depressive Disorders
- Treating Resistant Hypertension
- Duloxetine Pharmacokinetics in Pediatric Patients
- Rapid Clozapine Titration
Copyright © 2013 M.J. Powers & Company Publishers. All rights reserved
MJ Powers & Co Publishers is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.